Inhibiting p38 by SB202190 suppressed hypoxia-activated NF-κB, and reduced TF expression and activity to the similar levels as treatment of Ro 106-9920, suggesting that p38 acts as a positive regulator of NF-κB-mediated TF expression in hypoxic A549 cancer cells. This evidence concerns the gene MAPK14 and cancer.